India to United Arab Emirates: Guaifenesin Export Trade Route

The India to United Arab Emirates Guaifenesin corridor is one of India's established pharmaceutical export routes, with 12 shipments documented worth a combined $345.5K USD. The route is dominated by CHANDRA BHAGAT PHARMA LIMITED, which alone accounts for roughly 59% of all export value, reflecting the consolidated nature of India's guaifenesin manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $28.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 34.3%, placing it at rank #3 among India's top guaifenesin export destinations globally.

On the import side, key buyers of Indian guaifenesin in United Arab Emirates include TO THE ORDER, LAZERHEAD CAPITAL LIMITED, ERRA. TO THE ORDER is the single largest importer with 7 shipments valued at $202.8K USD.

India's guaifenesin exports to United Arab Emirates are driven primarily by a handful of large-scale manufacturers. CHANDRA BHAGAT PHARMA LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in United Arab Emirates benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CHANDRA BHAGAT PHARMA LIMITED, LAZERHEAD LIFESCIENCES PRIVATE LIMITED, MVC PHARMACEUTICALS — together account for 100% of total trade value on this route. The average shipment value of $28.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as theophylline & guaifenesin oral solutionusp 50mg & 30mg/5ml; solution parenteral 30mg/1ml pack: 10x10x1ml brand name: lnos and guaifenesin oral solution usp 100mg/5ml-, suggesting that buyers in United Arab Emirates tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER is the largest importer with 7 shipments worth $202.8K USD — representing 59% of all guaifenesin imports from India on this route.